These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7333700)

  • 1. Incidence of ovarian cancer in relation to the use of oral contraceptives.
    Weiss NS; Lyon JL; Liff JM; Vollmer WM; Daling JR
    Int J Cancer; 1981 Dec; 28(6):669-71. PubMed ID: 7333700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Events of reproductive life and the incidence of epithelial ovarian cancer.
    Risch HA; Weiss NS; Lyon JL; Daling JR; Liff JM
    Am J Epidemiol; 1983 Feb; 117(2):128-39. PubMed ID: 6681935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
    Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
    Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete pregnancies and risk of ovarian cancer (Washington, United States).
    Chen MT; Cook LS; Daling JR; Weiss NS
    Cancer Causes Control; 1996 Jul; 7(4):415-20. PubMed ID: 8813429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncontraceptive estrogen use and the occurrence of ovarian cancer.
    Weiss NS; Lyon JL; Krishnamurthy S; Dietert SE; Liff JM; Daling JR
    J Natl Cancer Inst; 1982 Jan; 68(1):95-8. PubMed ID: 6948131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of endometrial cancer in relation to the use of oral contraceptives.
    Weiss NS; Sayvetz TA
    N Engl J Med; 1980 Mar; 302(10):551-4. PubMed ID: 7351890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and neoplasia of the ovary.
    Stanford JL
    Contraception; 1991 Jun; 43(6):543-56. PubMed ID: 1868732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial ovarian cancer and combination oral contraceptives.
    Rosenberg L; Shapiro S; Slone D; Kaufman DW; Helmrich SP; Miettinen OS; Stolley PD; Rosenshein NB; Schottenfeld D; Engle RL
    JAMA; 1982 Jun; 247(23):3210-2. PubMed ID: 7045417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States).
    Adler AI; Weiss NS; Kamb ML; Lyon JL
    Cancer Causes Control; 1996 Jul; 7(4):475-8. PubMed ID: 8813436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the association of oral contraceptives and ovarian cancer.
    Cramer DW; Hutchison GB; Welch WR; Scully RE; Knapp RC
    N Engl J Med; 1982 Oct; 307(17):1047-51. PubMed ID: 7121514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.
    Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
    Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
    Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
    BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial and ovarian cancer and oral contraceptives--findings in a large cohort study.
    Vessey MP; Painter R
    Br J Cancer; 1995 Jun; 71(6):1340-2. PubMed ID: 7779735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian neoplasms, functional ovarian cysts, and oral contraceptives.
    Vessey M; Metcalfe A; Wells C; McPherson K; Westhoff C; Yeates D
    Br Med J (Clin Res Ed); 1987 Jun; 294(6586):1518-20. PubMed ID: 3111618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of the data collection process for a multicenter, population-based, case-control design.
    Wingo PA; Ory HW; Layde PM; Lee NC
    Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives as related to cancer and benign lesions of the breast.
    Fasal E; Paffenbarger RS
    J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and ovarian cancer.
    La Vecchia C; Franceschi S
    Eur J Cancer Prev; 1999 Aug; 8(4):297-304. PubMed ID: 10493304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reduction in risk of ovarian cancer associated with oral-contraceptive use.
    Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development
    N Engl J Med; 1987 Mar; 316(11):650-5. PubMed ID: 3821795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and epithelial ovarian cancer. Does dose matter?
    Sanderson M; Williams MA; Weiss NS; Hendrix NW; Chauhan SP
    J Reprod Med; 2000 Sep; 45(9):720-6. PubMed ID: 11027080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.